Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Pharmaceuticals Holding Co., Ltd
  6. Summary
    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

(601607)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
19.7 19.82 19.69 19.67 19.42 Last
14431170 15127150 13899280 15094760 15650340 Volume
-1.45% +0.61% -0.66% -0.10% -1.27% Change
Estimated financial data (e)
Sales 2021 224 B 34 635 M 34 635 M
Net income 2021 5 182 M 800 M 800 M
Net Debt 2021 26 788 M 4 133 M 4 133 M
P/E ratio 2021 11,2x
Yield 2021 2,56%
Sales 2022 244 B 37 703 M 37 703 M
Net income 2022 5 700 M 879 M 879 M
Net Debt 2022 16 124 M 2 488 M 2 488 M
P/E ratio 2022 9,78x
Yield 2022 2,95%
Capitalization 49 790 M 7 695 M 7 683 M
EV / Sales 2021 0,34x
EV / Sales 2022 0,27x
Nbr of Employees 48 136
Free-Float 61,1%
More Financials
Company
Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as... 
Sector
Drug Retailers
Calendar
08/31Earnings Release
More about the company
Ratings of Shanghai Pharmaceuticals Holding Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
07/19SHANGHAI PHARMACEUTICALS HOLDING CO. : Ex-dividend day for final dividend
FA
07/06SHANGHAI PHARMACEUTICALS : The Fortune 500 company Shanghai Pharmaceuticals ente..
AQ
07/06Shanghai Pharmaceuticals Holding Co., Ltd acquired Fimet Oy.
CI
06/29Shanghai Pharmaceuticals Holding Co., Ltd Approves Cash Dividend for the Year..
CI
05/27SHANGHAI PHARMACEUTICALS : Pharma to Buy Medical Equipment Maker From Affiliate ..
MT
05/27Shanghai Industrial Urban Unit to Provide Project Management Services to Shan..
MT
05/27Shanghai Pharmaceuticals Holding Co., Ltd entered into an equity transfer agr..
CI
05/20Shanghai Pharmaceuticals Holding Co., Ltd. Announces Obtaining Acceptance of ..
CI
05/18CANSINO BIOLOGICS : Bio, Shanghai Pharma Inject $171 Million in Additional Fundi..
MT
05/12SHANGHAI PHARMACEUTICALS : Connected transaction proposed non-public issuance of..
PU
05/12SHANGHAI PHARMACEUTICALS : Pharma Seeks $2.2 Billion Funding from New, Existing ..
MT
05/11Shanghai Pharmaceuticals Holding Co., Ltd announced that it expects to receiv..
CI
04/28Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Fi..
CI
04/12TIANDA PHARMACEUTICALS : Renews Sales Deal with Shanghai Pharmaceuticals
MT
04/01FISSION URANIUM : Names New CFO
MT
More news
News in other languages on SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
2018Ardian lance la vente de l'allemand Riemser Pharma
2017SHANGHAI PHARMACEUTICALS : Vers une cession du fabricant américain de génériques..
2017Arbor courtisé par deux laboratoires chinois
2017Arbor courtisé par deux laboratoires chinois
2017Insider - Finanzinvestoren geben Stada noch nicht verloren
More news
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 19,42 CNY
Average target price 23,86 CNY
Spread / Average Target 22,9%
EPS Revisions
Managers and Directors
Man Cho President & Executive Director
Bo Shen Chief Financial Officer, Executive Director & VP
Jun Zhou Chairman
Liang Hong Independent Non-Executive Director
Jiang Nan Cai Independent Non-Executive Director
Sector and Competitors